Streamline Health Solutions, Inc. provides health information technology solutions and associated services for hospitals and health systems in the United States and Canada. It provides computer software-based solutions and auditing services, which captures, aggregates, and translates structured and unstructured data to deliver predictive insights. The company also offers coding and clinical documentation improvement (CDI) solutions, which includes integrated cloud-based software suite, CDI, and abstracting and physician query; and eValuator, a cloud-based pre-bill coding analysis platform. In addition, it provides financial management solutions, including accounts receivable management, denials management, claims processing, spend management, and audit management; patient care solutions; and custom integration services for CDI/abstracting, training, and audit services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.
IPO Year:
Exchange: NASDAQ
Website: streamlinehealth.net
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/21/2022 | $3.00 | Buy | Lake Street |
Streamline expects $4.5 million of additional liquidity will enable achievement of previously announced adjusted EBITDA breakeven of $15.5 million of installed SaaS ARR during the second half of fiscal 2024 Expanded board of directors with appointment of CEO Benjamin Stilwill and Matthew EtheridgeClosed private placement of unsecured subordinated notes and warrants and private placement of common stock resulting in aggregate gross proceeds of approximately $4.5 millionModified existing senior loan covenants Atlanta, GA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM) ("Streamline" or "the Company"), a leading provider of solutions that enable healthc
Lake Street resumed coverage of Streamline Health with a rating of Buy and set a new price target of $3.00
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
4/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
Net loss of ($2.8 million) during the second quarter of fiscal 2024 compared to a net loss of ($2.5 million) during the second quarter of fiscal 2023Adjusted EBITDA improved to a loss of ($0.3 million) for the second quarter of fiscal 2024 compared to a loss of ($0.9 million) for the second quarter of fiscal 2023Company reiterated $15.5 million implemented SaaS ARR adjusted EBITDA breakeven run rate expectationCompany updated expectation for achievement of SaaS ARR adjusted EBITDA breakeven run rate to the second half of fiscal 2025 ATLANTA, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions
ATLANTA, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced that it will release its financial results for the three month period ended July 31, 2024 on Wednesday September 11, 2024 after the close of the financial markets. The Company will conduct a conference call on Thursday, September 12, 2024, at 9:00 AM ET to review results and provide a corporate update. Interested parties can access the call by joining the live webcast: click here to register. You can also join
Net loss of ($2.7 million) during the first quarter of fiscal 2024 compared to net loss of ($2.9 million) during the first quarter of fiscal 2023Adjusted EBITDA improved to a loss of ($0.7 million) during the first quarter of fiscal 2024 vs. a loss of ($1.3 million) during the first quarter of fiscal 2023$15.6 million of Booked SaaS ACV as of April 30, 2024 vs. $15.0 million of booked SaaS ACV as of January 31, 2024Company reiterated $15.5 million implemented SaaS ARR adjusted EBITDA breakeven run rate expectation ATLANTA, June 11, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcar
ATLANTA, June 04, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced that it will release its financial results for the three month period ended April 30, 2024 on Tuesday June 11, 2024 after the close of the financial markets. The Company will conduct a conference call on Wednesday, June 12, 2024, at 9:00 AM ET to review results and provide a corporate update. Interested parties can access the call by joining the live webcast: click here to register. You can also join by phone by
14% growth of SaaS revenue in fiscal 2023 compared to fiscal 2022$0.4 million of adjusted EBITDA generated in the fourth quarter of fiscal 2023 compared to ($0.2 million) during the fourth quarter of fiscal 2022; $2.4 million of adjusted EBITDA improvement in fiscal 2023 vs. fiscal 2022($1.4 million) net loss during the fourth quarter of fiscal 2023, compared to ($2.2 million) during the fourth quarter of fiscal 2022$15.0 million of Booked SaaS ACV as of January 31, 2024; $15.6 million of Booked SaaS ACV as of April 29, 2024, above adjusted EBITDA breakeven run rate of $15.5 million of implemented SaaS ARR Atlanta, GA, April 29, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solu
Atlanta, GA, April 22, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced that it will release its financial results for the three and twelve month periods ended January 31, 2024 on Monday April 29, 2024 after the close of the financial markets. The Company will conduct a conference call on Tuesday, April 30, 2024, at 9:00 AM ET to review results and provide a corporate update. Interested parties can access the call by joining the live webcast: click here to register. You can also j
22% growth of SaaS revenue in the third quarter of fiscal 2023 compared to the third quarter of fiscal 2022$400 thousand of Adjusted EBITDA generated in the third quarter of fiscal 2023 compared to ($1.2) million during the third quarter of fiscal 2022$13.0 million of Booked SaaS ACV as of October 31, 2023; $14.5 million of Booked SaaS ACV as of December 13, 2023; $3.2 million unimplemented as of December 13, 2023Updated breakeven SaaS Annual Recurring Revenue (ARR) run rate to $15.5 millionAlso announced 2,300 bed health system opted to leverage RevID's automated charge reconciliation Atlanta, GA, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or
Atlanta, GA, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, announced today that it will release its financial results for the three month period ended October 31, 2023 on Wednesday December 13, 2023 after the close of the financial markets. The Company will conduct a conference call on Thursday, December 14, 2023, at 9:00 AM ET to review results and provide a corporate update. Interested parties can access the call by joining the live webcast: click here to register. You can also join
Executing strategic restructuring to reduce operating expenses and drive profitable growth of SaaS business; estimated annualized cost savings of approximately $5.8 millionReceived termination notice from legacy client with a $4.5M annualized revenue run rateBenjamin Stilwill appointed Chief Executive OfficerTee Green transitioning to Executive ChairmanBryant "B.J." Reeves appointed interim Chief Financial OfficerCompany to host conference call at 9:00AM Eastern Time on October 16, 2023 Atlanta, GA, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance,
13% growth of SaaS revenue in the first half of fiscal 2023 compared to the first half of fiscal 2022 Atlanta, GA, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the second quarter of 2023 which ended July 31, 2023. Fiscal Second Quarter and Six Months Ended July 31, 2023 GAAP Financial Results The following financial results have been prepared in accordance with Generally Accepted Accounting Principles ("GAAP"). Total
ATLANTA, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that is has signed a new contract for the use of eValuator with a 900-bed, Altera EHR-based health system serving northern Texas. This marks the fourth Texas health system to adopt eValuator, reinforcing Streamline Health's growing presence in the region. Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. eValuator's AI-enhance pre-bill code auditing ensures that providers can accurately capture, bill and ultimat
ATLANTA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- – Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has expanded its relationship with a leading academic medical center in Florida to include the recently released eValuator Quality Module. Streamline expects that this module will increase the SaaS revenues from its eValuator relationship with this client by 20%. Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. eValuator's AI-powered pre-bill code auditing analyzes 100% of encounters in real-time, en
ATLANTA, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has expanded its relationship with an existing eValuator client include the recently released eValuator Quality Module. Streamline expects that this module will increase the SaaS revenues from its eValuator relationship with this client by 25%. Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. eValuator's AI-powered pre-bill code auditing analyzes 100% of encounters in real-time, ensuring that provide
Atlanta, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has debuted a new quality module for eValuator and successfully implemented that module at an existing eValuator client. Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. eValuator's AI-enhanced pre-bill code auditing ensures that providers can accurately capture, bill and ultimately be paid for all the care they provide while avoiding denials. The eValuator quality module enables health systems to pros
ATLANTA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, today announced that it will proceed with a 1-for-15 reverse stock split (the "Reverse Stock Split") of its outstanding shares of Common Stock (the "Common Stock") following approval by its Board of Directors. The 1-for-15 ratio is within the range approved by the Company's stockholders at the Special Meeting of Stockholders held on September 19, 2024. The Reverse Stock Split is intended to bring the Company into compliance with the minimum bid price requirement for
Net loss of ($2.8 million) during the second quarter of fiscal 2024 compared to a net loss of ($2.5 million) during the second quarter of fiscal 2023Adjusted EBITDA improved to a loss of ($0.3 million) for the second quarter of fiscal 2024 compared to a loss of ($0.9 million) for the second quarter of fiscal 2023Company reiterated $15.5 million implemented SaaS ARR adjusted EBITDA breakeven run rate expectationCompany updated expectation for achievement of SaaS ARR adjusted EBITDA breakeven run rate to the second half of fiscal 2025 ATLANTA, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions
ATLANTA, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced that it will release its financial results for the three month period ended July 31, 2024 on Wednesday September 11, 2024 after the close of the financial markets. The Company will conduct a conference call on Thursday, September 12, 2024, at 9:00 AM ET to review results and provide a corporate update. Interested parties can access the call by joining the live webcast: click here to register. You can also join
ATLANTA, July 16, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has expanded its contract for the use of RevID with a 425-bed, Oracle-EHR based health system and extended the term for an additional 5 years. Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. RevID's automated charge reconciliation accelerates cash flow by ensuring that providers can accurately capture, bill and ultimately be paid for all the care they provide. "We are pleased with the continued trust
ATLANTA, July 02, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has signed a new contract for the use of eValuator with a 750-bed, Epic-EHR based medical center in Texas. During the pursuit of this relationship eValuator was TX-RAMP certified, enabling Streamline to pursue business with all Texas state funded health systems. Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. eValuator's AI-enhanced pre-bill code auditing ensures that providers can accurately capture,
Net loss of ($2.7 million) during the first quarter of fiscal 2024 compared to net loss of ($2.9 million) during the first quarter of fiscal 2023Adjusted EBITDA improved to a loss of ($0.7 million) during the first quarter of fiscal 2024 vs. a loss of ($1.3 million) during the first quarter of fiscal 2023$15.6 million of Booked SaaS ACV as of April 30, 2024 vs. $15.0 million of booked SaaS ACV as of January 31, 2024Company reiterated $15.5 million implemented SaaS ARR adjusted EBITDA breakeven run rate expectation ATLANTA, June 11, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. ("Streamline" or the "Company") (NASDAQ:STRM), a leading provider of solutions that enable healthcar
8-K - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
8-K - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
8-K - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
10-Q - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
8-K - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
DEF 14A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
PRE 14A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
S-8 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
8-K - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
10-Q - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Filer)
4 - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Issuer)
SC 13G - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
SC 13D/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
SC 13G/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
SC 13D/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
SC 13D/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
SC 13G - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
SC 13G - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
SC 13G/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
SC 13D/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
SC 13D/A - STREAMLINE HEALTH SOLUTIONS INC. (0001008586) (Subject)
Shares of Streamline Health Solutions, Inc. (NASDAQ:STRM) fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter EPS results. Streamline Health reported quarterly losses of 5 cents per share which missed the analyst consensus estimate of 4 cents per share. The company reported quarterly sales of $4.33 million which beat the analyst consensus estimate of $4.31 million, according to data from Benzinga Pro. Streamline Health Solutions shares dipped 23.3% to $0.4902 on Wednesday. Here are some other stocks moving in today’s mid-day session. Gainers DDC Enterprise Limited (NYSE:DDC) surged 101% to $1.04. DDC Enterprise said it has acqu
Gainers Longeveron (NASDAQ:LGVN) shares rose 112.1% to $1.74 during Wednesday's regular session. The market value of their outstanding shares is at $11.0 million. vTv Therapeutics (NASDAQ:VTVT) stock increased by 43.09% to $26.0. The market value of their outstanding shares is at $63.2 million. Avidity Biosciences (NASDAQ:RNA) shares increased by 32.32% to $38.27. The company's market cap stands at $3.6 billion. Cyclerion Therapeutics (NASDAQ:CYCN) stock rose 30.39% to $2.96. The company's market cap stands at $7.3 million. Telesis Bio (NASDAQ:TBIO) stock moved upwards by 22.53% to $3.86. The company's market cap stands at $6.4 million. Autonomix Medical (NASDAQ:AMIX) stock rose 20.94%
Gainers Avidity Biosciences (NASDAQ:RNA) shares rose 24.5% to $36.0 during Wednesday's pre-market session. The company's market cap stands at $3.4 billion. Molecular Partners (NASDAQ:MOLN) shares moved upwards by 18.43% to $5.91. The market value of their outstanding shares is at $196.1 million. Longeveron (NASDAQ:LGVN) shares increased by 15.84% to $0.95. The company's market cap stands at $6.0 million. TRACON Pharma (NASDAQ:TCON) shares increased by 15.74% to $1.25. The market value of their outstanding shares is at $3.3 million. Oramed Pharmaceuticals (NASDAQ:ORMP) stock moved upwards by 14.49% to $2.37. The market value of their outstanding shares is at $96.2 million. NovaBay Pharm
Due to the continued unpredictability of timing related to the closing of new contracts, the Company has not provided more specific guidance related to the timing of bookings.
Streamline Health Solns (NASDAQ:STRM) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 25 percent. This is unchanged from the same period last year. The company reported quarterly sales of $4.33 million which beat the analyst consensus estimate of $4.31 million by 0.46 percent. This is a 18.79 percent decrease over sales of $5.33 million the same period last year.
Gainers Elutia (NASDAQ:ELUT) stock rose 24.2% to $4.31 during Tuesday's regular session. The market value of their outstanding shares is at $104.9 million. Trinity Biotech (NASDAQ:TRIB) stock rose 20.61% to $2.75. The company's market cap stands at $26.0 million. Akari Therapeutics (NASDAQ:AKTX) shares moved upwards by 20.26% to $3.03. The company's market cap stands at $35.5 million. Kronos Bio (NASDAQ:KRON) shares increased by 16.71% to $1.11. The market value of their outstanding shares is at $66.7 million. Black Diamond Therapeutic (NASDAQ:BDTX) shares increased by 15.72% to $5.91. The market value of their outstanding shares is at $332.7 million. Streamline Health Solns (NASDAQ:ST